ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2015

Recognizing Two Distinct Clinical Phenotypes in Muckle-Wells Syndrome

J B. Kuemmerle-Deschner1, Samuel Dembi Samba1, Isabelle Kone-Paut2, Isabelle Marie2, Pascal N. Tyrrell3 and Susanne M. Benseler4, 1Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, 2Pédiatrie Générale, CHU Bicêtre, Paris, France, 3Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Muckle-Wells syndrome and inflammation

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: The diagnosis of Muckle-Wells syndrome remains challenging due to the variable and often non-specific clinical presentation. The aim of this study was to identify key variables associated with time to diagnosis in patients with MWS.

Methods: A cohort study of consecutive patients with a clinical diagnosis of MWS plus genetic evidence of an NLRP3-mutation was conducted at two centres for autoinflammatory diseases. Demographic information, mutation subtype, clinical phenotype, detailed access to care data, and information about duration of symptoms and preclinical evaluation were collected. Presenting variables were compared between groups of patients with a diagnosis in childhood compared to adulthood.

Results: A total of 34 patients were included (16 males, 18 females), the median age at diagnosis of MWS was 31.5 years (0.5-75). Patients diagnosed during childhood most commonly complained of musculoskeletal symptoms (62%), fever (54%), headache (46%) and abdominal pain (31%), while those diagnosed as adults had musculoskeletal symptoms (86%), hearing loss (52%) and decreased performance (29%). Data driven clustering strategies identified two distinct clinical phenotypes of MWS: the “inflammatory phenotype”, most commonly found in patients diagnosed in childhood was associated with fever, rash, headache and abdominal pain. Patients diagnosed as adults showed a more “organ –disease” phenotype characterized by musculoskeletal symptoms, skin rash, hearing loss and eye disease.

Conclusion: Two distinct clinical phenotypes may be identified in patients with MWS. These are closely related to the time of diagnosis. The presence of these two distinct clinical phenotypes has to be considered when developing diagnostic criteria for MWS.


Disclosure:

J. B. Kuemmerle-Deschner,
None;

S. D. Samba,
None;

I. Kone-Paut,
None;

I. Marie,
None;

P. N. Tyrrell,
None;

S. M. Benseler,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/recognizing-two-distinct-clinical-phenotypes-in-muckle-wells-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology